ANI Pharmaceuticals reported $2.04 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.97 1.63 Feb/26 2026
FY2025Q3 Sep/2025 2.04 1.71 1.34 Nov/07 2025
FY2025Q2 Jun/2025 1.80 1.43 1.02 Aug/08 2025
FY2025Q1 Mar/2025 1.70 1.12 1.21 May/09 2025
FY2024Q4 Dec/2024 1.63 1.45 1.00 Feb/28 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
ANI Pharmaceuticals USD 2.04 0.24 Sep/2025
Aurora Cannabis CAD -1 0.73 Sep/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Hikma Pharmaceutical USD 0.54 0.06 Jun/2025
Knight Therapeutics CAD -0.03 0.07 Jun/2025
Novartis USD 2.02 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Sun Pharmaceuticals INR 12.8 0.2 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025